fatigue; Body aches; redness at the injection site; swelling at the injection site; Lymph nodes in arm and around collar bone are swollen to size of golf balls; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), LYMPHADENOPATHY (Lymph nodes in arm and around collar bone are swollen to size of golf balls), PAIN (Body aches), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL), DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) and IBUPROFEN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes in arm and around collar bone are swollen to size of golf balls). On 21-Jan-2021, the patient experienced FATIGUE (fatigue), PAIN (Body aches), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, FATIGUE (fatigue), LYMPHADENOPATHY (Lymph nodes in arm and around collar bone are swollen to size of golf balls), PAIN (Body aches), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), LYMPHADENOPATHY (Lymph nodes in arm and around collar bone are swollen to size of golf balls), PAIN (Body aches), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL), DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) and IBUPROFEN for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes in arm and around collar bone are swollen to size of golf balls). On 21-Jan-2021, the patient experienced FATIGUE (fatigue), PAIN (Body aches), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, FATIGUE (fatigue), LYMPHADENOPATHY (Lymph nodes in arm and around collar bone are swollen to size of golf balls), PAIN (Body aches), INJECTION SITE ERYTHEMA (redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.